3-Quinuclidinyl thiochromane-4-carboxylate
3-Quinuclidinyl thiochromane-4-carboxylate

3-Quinuclidinyl thiochromane-4-carboxylate (QTCC) is a chemical compound that belongs to the class of quinuclidine derivatives. It is known for its potential applications in pharmacology and neuroscience due to its interaction with muscarinic acetylcholine receptors.
Chemical Structure[edit]
3-Quinuclidinyl thiochromane-4-carboxylate is characterized by the presence of a quinuclidine ring, which is a bicyclic amine, and a thiochromane moiety. The compound also contains a carboxylate group, which contributes to its chemical reactivity and potential biological activity.
Synthesis[edit]
The synthesis of 3-Quinuclidinyl thiochromane-4-carboxylate involves the reaction of quinuclidine with thiochromane-4-carboxylic acid. The process typically requires the use of specific reagents and conditions to ensure the formation of the desired ester linkage.
Pharmacological Properties[edit]
3-Quinuclidinyl thiochromane-4-carboxylate is studied for its ability to interact with muscarinic acetylcholine receptors, which are a subtype of acetylcholine receptors. These receptors are involved in various physiological processes, including neurotransmission, smooth muscle contraction, and glandular secretion.
Applications in Research[edit]
Due to its interaction with muscarinic receptors, QTCC is used in research to study the effects of muscarinic receptor modulation. It serves as a tool in neuroscience to understand the role of these receptors in the central nervous system and their potential implications in neurological disorders.
Safety and Handling[edit]
As with many chemical compounds, proper safety measures should be taken when handling 3-Quinuclidinyl thiochromane-4-carboxylate. It is important to use appropriate personal protective equipment and follow laboratory safety protocols to prevent exposure and potential hazards.
Related Pages[edit]
3-Quinuclidinyl thiochromane-4-carboxylate[edit]
-
Structure of 3-Quinuclidinyl thiochromane-4-carboxylate
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian